ROLE OF THE KNOWN MUCOLYTICS IN MUCOVISCIDOSIS THERAPY
The primary objective in the mucoviscidosis therapy is to ensure normal rheology of respiratory secretion for effective evacuationthereof from the bronchial tree and nasal sinuses. Enzyme drug dornase alfa features the best evidence base for effectiveness and safety of use to treat mucoviscidosis am...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Paediatrician Publishers, LLC
2014-11-01
|
| Series: | Pediatričeskaâ Farmakologiâ |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/44 |